Keyphrases
Beneficial Effects
12%
Cardiac Remodeling
12%
Cardiac Resynchronization Therapy
100%
Cellular Level
12%
Chronic Heart Failure
100%
Flow Cytometry
12%
Functional Characterization
12%
Heart Failure Patients
75%
In Vitro Activation
12%
Inflammatory Conditions
12%
Inflammatory Immune Response
12%
Inflammatory Process
12%
Inflammatory Response
12%
Interleukin-2
12%
Non-responders
25%
Regulatory T (Treg) Cells
25%
Regulatory T Cells
100%
T Cell Subpopulations
12%
T Cells
37%
T Cytotoxic Cells
25%
Trial Registration
12%
Medicine and Dentistry
Cardiac Resynchronization Therapy
100%
Cytotoxic T-Cell
18%
Disease
9%
Flow Cytometry
9%
Heart Failure
100%
Heart Ventricle Remodeling
9%
Immune Response
9%
In Vitro
9%
Observational Study
9%
Prospective Study
9%
Regulatory T Cell
100%
Serositis
27%
Symptom
9%
T Cell
27%
T Lymphocyte Subpopulation
9%
Tumor Necrosis Factor
9%
Immunology and Microbiology
Cardiac Resynchronization Therapy
100%
Cell Level
12%
Cytotoxic T Cell
25%
Immune Response
12%
Inflammation Response
12%
Normal Human
12%
Regulatory T Cell
100%
T Cell
37%
T Lymphocyte Subpopulation
12%
Tumor Necrosis Factor
12%
Nursing and Health Professions
Cardiac Resynchronization Therapy
100%
Cell Level
9%
Disease
9%
Flow Cytometry
9%
Heart Failure
100%
Heart Ventricle Remodeling
9%
Inflammation
27%
Symptom
9%
Tumor Necrosis Factor
9%